Key Highlights
- A new study suggests that restoring normal NAD+ levels in the brains of mice can fully reverse markers of advanced Alzheimer’s disease.
- The research was led by scientists at University Hospitals Cleveland Medical Center and found that a medication called P7C3-A20 helped to restore cognitive function in mice with severe Alzheimer’s symptoms.
- Scientists argue that this breakthrough could provide cautious optimism for the potential reversal of certain forms of dementia, though clinical trials in humans are still needed.
- The study highlights the importance of NAD+ in brain health and its decline as a factor in age-related cognitive decline.
Reviving Cognitive Function: The Potential Breakthrough in Alzheimer’s Treatment
A groundbreaking study suggests that restoring normal levels of NAD+, an essential enzyme for energy production, may hold the key to reversing Alzheimer’s disease. According to researchers at University Hospitals Cleveland Medical Center, a medication called P7C3-A20 successfully restored cognitive function and reversed brain changes in mice with advanced Alzheimer’s symptoms.
Understanding NAD+ and Its Role
NAD+, or nicotinamide adenine dinucleotide, is crucial for energy production within cells and plays a significant role in maintaining cellular health. Dr. Andrew A.
Pieper, director of the Brain Health Medicines Center at Harrington Discovery Institute, explains that NAD+ naturally declines with age, leading to decreased cell maintenance and survival functions.
“When NAD+ falls below necessary levels, cells cannot effectively perform essential maintenance and survival functions,” Dr. Pieper told Fox News Digital. This decline is particularly critical for the brain, which consumes about 20% of a person’s body’s energy and requires high levels of NAD+ for cellular energy production and DNA repair.
Reversing Advanced Alzheimer’s in Mice
The study involved two models of Alzheimer’s disease in mice and human brain tissue, revealing severe declines in NAD+ levels. By administering P7C3-A20, the researchers were able to normalize NAD+ levels in the brains of advanced-stage Alzheimer’s mice.
This treatment not only halted the progression of the disease but fully reversed amyloid and tau build-up, two hallmark features of Alzheimer’s. Moreover, it restored cognitive function to a level equivalent to that seen in healthy mice.
Phosphorylated tau 217 levels also normalized, an important clinical biomarker used in human Alzheimer’s research.
Dr. Pieper stated, “Our experiments provide a proof of principle that some forms of dementia may not be inevitably permanent.” This finding offers cautious optimism for the potential reversal of certain types of dementia but notes that further research is necessary to understand its applicability in humans.
Implications and Future Research
The study’s findings are significant, as they challenge long-held beliefs about Alzheimer’s being an irreversible condition. However, researchers caution that while the results are promising, the treatment will need to be tested in clinical trials with human patients before any definitive conclusions can be drawn.
Dr. Pieper also highlighted potential risks associated with NAD+-modulating supplements, warning that they could push levels to excessively high levels and potentially promote cancer if not used appropriately.
The research builds on previous findings from the same lab demonstrating that restoring NAD+ balance helped speed recovery after severe traumatic brain injury.
The team plans to continue exploring the impact of brain energy balance on cognitive health and investigate whether similar strategies could benefit other age-related neurodegenerative diseases.
While more work is needed, this breakthrough opens new avenues for treating Alzheimer’s disease and other forms of dementia. Future research will focus on translating these findings from animal models to human patients and understanding the broader implications for brain health.
Preventing Alzheimer’s: Lifestyle Measures
Dr. Pieper also emphasized that lifestyle measures can significantly impact cognitive resilience, including sufficient sleep, following a MIND or Mediterranean diet, staying cognitively and physically active, maintaining social connections, addressing hearing loss, protecting the head from injury, limiting alcohol consumption, and controlling cardiovascular risk factors.
“Alzheimer’s is a complex, multifactorial, uniquely human disease,” he added. “These lifestyle measures can support brain health and potentially reduce the risk of developing dementia.”
The study was published in the journal Cell Reports Medicine last week, marking an important step forward in understanding and potentially reversing Alzheimer’s disease through targeted NAD+ restoration.
Melissa Rudy is a senior health editor at Fox News Digital. For more health stories, visit the Fox News Health section.
